J Korean Soc Transplant.  2002 Dec;16(2):215-218.

Malignancy in Renal Transplant Recipients

Affiliations
  • 1Department of General Surgery, Maryknoll Hospital, Busan, Korea. mkhgs@yahoo.co.kr

Abstract

PURPOSE: Survival rate after renal transplantation has increased in according to the prolonged graft survival due to a development of new immunosuppressive agents and operative techniques. Therefore, the develpment of malignancy in renal transplant recipients has become the major cause of morbidity and mortality.
METHODS
The retrospective analysis was performed in 4 patients with malignancy among the 315 patients who underwent kidney transplantation in our hospital from August 1990 to March 2001 and 1 patient with malignancy who underwent kidney transplantation in other hospital and was followed up in our hospital.
RESULTS
In five malignancy, 3 were adenocarcinoma in stomach, 1 lobular carcinoma in breast and 1 squamous cell carcinoma in uterine cervix. The mean age of these patients at diagnosis of malignancy was 48.4 (35~60) and the average interval between renal transplantation and diagnosis of malignancy was 69.8 months. Surgical resection was done in all five patients. Chemotherapy was performed in 1 patients with advanced gastric cancer and 1 patient with breast cancer. Four patients are now alive and one patient was lost during follow-up period.
CONCLUSION
We reviewed the incidences and types of malignancy after renal transplantation in our hospital. Regular screening and careful surveillance are highly recommended in patients after renal transplantation.

Keyword

Malignancy; Renal transplantation

MeSH Terms

Adenocarcinoma
Breast
Breast Neoplasms
Carcinoma, Lobular
Carcinoma, Squamous Cell
Cervix Uteri
Diagnosis
Drug Therapy
Female
Follow-Up Studies
Graft Survival
Humans
Immunosuppressive Agents
Incidence
Kidney Transplantation
Mass Screening
Mortality
Retrospective Studies
Stomach
Stomach Neoplasms
Survival Rate
Transplantation*
Immunosuppressive Agents
Full Text Links
  • JKSTN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr